← Back to Clinical Trials
Recruiting Phase 2 NCT06616207

NCT06616207 Topical 10% Povidone-Iodine in Preventing White Spots

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06616207
Status Recruiting
Phase Phase 2
Sponsor University of Washington
Condition White Spot Lesions
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2024-09-13
Primary Completion 2027-03-31

Trial Parameters

Condition White Spot Lesions
Sponsor University of Washington
Study Type INTERVENTIONAL
Phase Phase 2
Enrollment 80
Sex ALL
Min Age 10 Years
Max Age 17 Years
Start Date 2024-09-13
Completion 2027-03-31
Interventions
PlaceboPovidone-iodine solution

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if topical application on the all surface of 10% Povidone Iodine (Povi-One) in healthy participants in transitional or permanent dentition (10-17 y) prevents new white spot lesions in the maxillary anterior teeth at 1 year of follow-up. Researchers will compare Povi-One to a placebo to see if Povi-One works to prevent new white spot lesions. It will also learn about the safety of topical 10% Povidone Iodine. The main questions it aims to answer are: 1. Does Povi-One prevent the development of any white spot lesion on the surface of maxillary anterior teeth? 2. Does Povi-One lower the probability of any International Caries Detection and Assessment System (ICDAS) score greater than 0 and mean modified Löe-Silness Gingival Index (GI) in the intervention group? Researchers will 1. Score GI without cleaning participants teeth, then score ICDAS of maxillary and mandibular incisors after participants brush and floss their teeth and take a photograph of maxillary 6 anterior teeth 2. Apply Povi-one (or control) at the consultation appointment before placing fixed orthodontic appliances and 3, 6, and 9 months after appliance placement Researchers will 1. Recall using Zoom 24-48 hours after the first application of Povi-One and examine the participant's mouth for oral lesions using a structured paper checklist 2. Interview the caregiver to complete a paper questionnaire on adverse effects Researchers will 1. Score GI, and then score ICDAS of maxillary and mandibular incisors in 6, 12 months after appliance placement 2. Evaluate the development of white spot lesions on maxillary central and lateral incisors in 6, and 12 months after appliance placement

Eligibility Criteria

Inclusion Criteria: * Healthy children and teens (10-17 years old) * Transitional or permanent dentition of at least 4 permanent anterior teeth in each arch * Full fixed appliance orthodontic treatment is expected to last at least one year Exclusion Criteria: * Allergies to iodine * Chronic prophylactic use of antibiotics * Diagnosis of thyroid disease * Conditions that could impair routine oral hygiene procedures. * Pregnant at enrollment

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology